Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN- γ and expanding CD4 + Foxp3 + T cells in concordant heart transplantation

Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4+Foxp3+ T cells in concordant heart transplantation Laboratory Investigation 96, 820 (August 2016). doi:10.1038/labinvest.2016.54 Authors: Chen Dai, Fang-Na Lu, Ning Jin, Bo Yang, Chang Gao, Bin Zhao, Jia-Zhao Fu, Shi-Fu Hong, Han-Ting Liang, Li-Hong Chen, Zhi-Shui Chen, Jie Chen & Zhong-Quan Qi
Source: Laboratory Investigation - Category: Laboratory Medicine Authors: Source Type: research